Status:
COMPLETED
Incidence of Occluded Culprit Arteries and Impact of Coronary Collaterals on Outcome in Patients With NSTEMI
Lead Sponsor:
University of Jena
Conditions:
NSTEMI
Eligibility:
All Genders
18-90 years
Phase:
PHASE4
Brief Summary
It is assumed that patients with non-ST-elevation myocardial infarctions (NSTEMI) showing an infero- or posterolateral occluded culprit artery (OCA) during diagnostic angiography frequently elude stan...
Detailed Description
We examined consecutive NSTEMI patients within 48 h of symptom onset. All patients underwent early invasive angiography plus optimal medical therapy. We compared baseline characteristics, procedural f...
Eligibility Criteria
Inclusion
- age between 18 and 90 years,
- onset of angina pectoris at rest \<24 h or crescendo angina in recent weeks with symptoms under minimal exertion or at rest lasting \<24 h,
- elevated troponin T ≥0.03 µg/L and
- written informed consent.
Exclusion
- persistent angina,
- ST-segment elevation myocardial infarction (STEMI),
- hemodynamic instability including cardiogenic shock,
- oral anticoagulation therapy,
- contraindications for glycoprotein IIb/IIIa inhibitors,
- other disease with life expectancy \<6 months,
- known coagulopathy,
- pregnancy,
- other suspected causes of troponin elevation as myocarditis, secondary to hypertensive crisis, or after cardiac decompensation,
- no ability to consent, and
- participation in another study.
Key Trial Info
Start Date :
July 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
602 Patients enrolled
Trial Details
Trial ID
NCT01159366
Start Date
July 1 2006
End Date
January 1 2010
Last Update
July 12 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Leipzig
Leipzig, Germany, 04289